UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~September~~March 3031, ~~2022~~ 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-39698

BETTER WORLD ACQUISITION CORP.

(Exact Name of Registrant as Specified in Its Charter)

Delaware		85-2448447
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

775 Park Avenue

New York, New York 10021

(Address of principal executive offices)

(212) 450-9700

(Registrant’s telephone number)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Shares of Common Stock, par value $0.0001 per share	BWAC	The Nasdaq Stock Market LLC
Redeemable Warrants, each whole warrant exercisable for one share of Common Stock for $11.50 per share	BWACW	The Nasdaq Stock Market LLC
Units, each consisting of one share of Common Stock and one Redeemable Warrant	BWACU	The Nasdaq Stock Market LLC

Indicate by check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large, accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of ~~November~~May 1419, ~~2022~~2023, 76,~~700~~487,~~523~~070 shares of common stock, par value $0.0001 per share, were issued and outstanding.

BETTER WORLD ACQUISITION CORP.

FORM 10-Q FOR THE QUARTER ENDED ~~SEPTEMBER~~MARCH 3031, ~~2022~~ 2023

TABLE OF CONTENTS

		Page
Part I. Financial Information		1
Item 1. Financial Statements		1
Condensed Balance Sheets as of September 30, 2022 (Unaudited) and December 31, 2021		1
Condensed Consolidated Balance Sheets as of March 31, 2023 (Unaudited) and December 31, 2022		1
Unaudited Condensed Statements of Operations for the three and nine months ended September 30, 2022 and 2021		2
Unaudited Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022		2
Unaudited Condensed Statements of Changes in Stockholders’ Deficit for the three and nine months ended September 30, 2022 and 2021		3
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the three months ended March 31, 2023 and 2022		3
Unaudited Condensed Statements of Cash Flows for the nine months ended September 30, 2022 and 2021		4
Unaudited Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022		4
Notes to Condensed Financial Statements (Unaudited)		5
Notes to Condensed Consolidated Financial Statements (Unaudited)		5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		2123
Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk		26
Item 3. Quantitative and Qualitative Disclosures About Market Risk		28
Item 4. Controls and Procedures		2628
Part II. Other Information		2729
Item 1. Legal Proceedings		2729
Item 1A. Risk Factors		2729
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		2829
Item 3. Defaults Upon Senior Securities		2829
Item 4. Mine Safety Disclosures		2829
Item 5. Other Information		2829
Item 6. Exhibits		29
Part III. Signatures		30

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

BETTER WORLD ACQUISITION CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

	September 30, 2022			December 31, 2021
	March 31, 2023			December 31, 2022
	(Unaudited)
ASSETS
Current assets
Cash	$	83141,~~760~~465		$	~~278~~2,~~197~~369
Prepaid expenses and other current assets		4897,~~251~~417			3044,~~805~~095
Total Current Assets		~~132~~238,~~011~~882			~~309~~46,~~002~~464
Cash and marketable securities held in Trust Account		4432,~~203~~224,~~481~~663			~~128~~44,~~790~~696,~~008~~624
TOTAL ASSETS	$	4432,~~335~~463,~~492~~545		$	~~129~~44,~~099~~743,~~010~~088
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities - Accounts payable and accrued expenses	$	560,689		$	430,800
Current Liabilities
Deferred legal fees		1,371,549			1,009,868
Accounts payable and accrued expenses	$	898,797		$	703,233
Convertible promissory note – related party, at fair value		913,900			958,400
Income taxes payable		128,063			73,932
Warrant Liabilities		422,846			2,641,204
Excise taxes payable		128,657			—
Income taxes payable		27,528			—
Advances from related parties		710,000			—
Total Liabilities		3,296,512			5,040,272
Convertible promissory note – related party, at fair value		914,700			901,500
Deferred legal fees		1,821,825			1,654,062
Total Current Liabilities		4,602,042			3,332,727
Warrant liabilities		581,414			528,558
Total Liabilities		5,183,456			3,861,285
Commitments and Contingencies (Note 6)
Common stock subject to possible redemption; $0.0001 par value; 4,213,453 shares at $10.49 per share redemption value as of September 30, 2022 and 12,618,600 shares at $10.20 per share redemption value as of December 31, 2021		44,203,481			128,709,720
Common stock subject to possible redemption, $0.0001 par value; 3,000,000 shares at $10.78 per share redemption value as of March 31, 2023 and 4,213,453 shares at $10.59 per share redemption value as of December 31, 2022		32,352,423			44,632,414
Stockholders’ Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding		—			—
Common stock, $0.0001 par value; 50,000,000 shares authorized; 3,487,070 shares issued and outstanding (excluding 4,213,453 and 12,618,600 shares subject to possible redemption) at September 30, 2022 and December 31, 2021, respectively		348			348
Common stock, $0.0001 par value; 50,000,000 shares authorized; 3,487,070 shares issued and outstanding (excluding 3,000,000 and 4,213,453 shares subject to possible redemption) at March 31, 2023 and December 31, 2022, respectively		348			348
Accumulated deficit		(35,~~164~~072,~~849~~682	)		(43,~~651~~750,~~330~~959	)
Total Stockholders’ Deficit		(35,~~164~~072,~~501~~334	)		(43,~~650~~750,~~982~~611	)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	4432,~~335~~463,~~492~~545		$	~~129~~44,~~099~~743,~~010~~088

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

BETTER WORLD ACQUISITION CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

	Three Months Ended September 30,						Nine Months Ended September 30,
	For the Three Months Ended March 31,
	2022			2021			2022			2021
	2023			2022
Operational costs	$	~~396~~776,~~066~~732		$	~~735~~504,~~695~~099		$	~~1,327,272~~		$	~~1,148,802~~
Loss from operations		(~~396~~776,~~066~~732	)		(~~735~~504,~~695~~099	)		~~(1,327,272~~	)		~~(1,148,802~~	)
Other income (expense):
Interest earned on marketable securities held in Trust Account		254,709			23,138			423,734			58,976
Interest earned on cash and marketable securities held in Trust Account		289,547			52,360
Unrealized gain (loss) on marketable securities held in Trust Account		1,078			(4,654	)		—			(5,829	)
Unrealized gain on marketable securities held in Trust Account		—			17,283
Change in fair value of Private Warrants liabilities		(~~106~~52,~~018~~856	)		21,~~192~~744,~~941~~591			~~2,218,358~~			~~3,302,913~~
Change in fair value of convertible promissory note – related party		1(13,~~113,700~~200	)		—337,260			~~2,119,960~~			—
Other income, net		1223,~~263,469~~491			2,~~211~~151,~~425~~494			~~4,762,052~~			~~3,356,060~~
Income before provision for income taxes		867,403			1,475,730			3,434,780			2,207,258
(Loss) Income before provision for income taxes		(553,241	)		1,647,395
Provision for income taxes		(2354,~~249~~131	)		—			~~(27,528~~	)		—
Net income	$	844,154		$	1,475,730		$	3,407,252		$	2,207,258
Net (loss) income	$	(607,372	)	$	1,647,395
Basic and diluted weighted average shares outstanding, redeemable common stock		53,~~591~~606,~~938~~727			12,618,600			~~9,268,327~~			~~12,618,600~~
Basic and diluted net income per share, redeemable common stock	$	0.09		$	0.09		$	0.27		$	0.14
Basic and diluted net (loss) income per share, redeemable common stock	$	(0.09	)	$	0.10
Basic and diluted weighted average shares outstanding, non-redeemable common stock		3,487,070			3,487,070			~~3,487,070~~			~~3,487,070~~
Basic and diluted net income per share, non-redeemable common stock	$	0.09		$	0.09		$	0.27		$	0.14
Basic and diluted net (loss) income per share, non-redeemable common stock	$	(0.09	)	$	0.10

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

BETTER WORLD ACQUISITION CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(UNAUDITED)

FOR THE THREE ~~AND NINE~~ MONTHS ENDED ~~SEPTEMBER 30~~MARCH 31, ~~2022~~2023

	Common Stock				Additional Paid			Accumulated			Total Stockholders’
	Shares		Amount		in Capital			Deficit			Deficit
Balance – January 1, 2022		3,487,070	$	348	$	—		$	(4,651,330	)	$	(4,650,982	)
Balance – January 1, 2023		3,487,070	$	348	$	—		$	(3,750,959	)	$	(3,750,611	)
Accretion for common stock to redemption amount		—		—		—			(1585,~~261,860~~694	)		(1585,~~261,860~~694	)
Net income		—		—		—			1,647,395			1,647,395
Excise taxes on stock redemption		—		—		—			(128,657	)		(128,657	)
Balance – March 31, 2022 (unaudited)		3,487,070	$	348		—		$	(4,265,795	)	$	(4,265,447	)
Net loss		—		—		—			(607,372	)		(607,372	)
Accretion for common stock to redemption amount		—		—		—			(500,000	)		(500,000	)
Balance – March 31, 2023 (unaudited)		3,487,070	$	348		—		$	(5,072,682	)	$	(5,072,334	)
Net income		—		—		—			915,703			915,703
Balance – June 30, 2022 (unaudited)		3,487,070	$	348		—		$	(3,850,092	)	$	(3,849,744	)
Accretion for common stock to redemption amount		—		—		(346,400	)		(158,911	)		(505,311	)
Promissory note proceeds in excess of initial fair value		—		—		346,400			—			346,400
Net income		—		—		—			844,154			844,154
Balance – September 30, 2022 (unaudited)		3,487,070	$	348		—		$	(3,164,849	)	$	(3,164,501	)

FOR THE THREE ~~AND NINE~~ MONTHS ENDED ~~SEPTEMBER 30~~MARCH 31, ~~2021~~2022

	Common Stock				Additional Paid		Accumulated			Total Stockholders’
	Shares		Amount		in Capital		Deficit			Deficit
Balance – January 1, 2021		3,487,070	$	348	$	—	$	(5,489,693	)	$	(5,489,345	)
Balance – January 1, 2022		3,487,070	$	348	$	—	$	(4,651,330	)	$	(4,650,982	)
Net income		—		—		—		832,646			832,646
Accretion for common stock to redemption amount		—		—		—		(1,261,860	)		(1,261,860	)
Balance – March 31, 2021 (unaudited)		3,487,070	$	348		—	$	(4,657,047	)	$	(4,656,699	)
Net income		—		—		—		1,647,395			1,647,395
Net loss		—		—		—		(101,118	)		(101,118	)
Balance – March 31, 2022 (unaudited)		3,487,070	$	348		—	$	(4,265,795	)	$	(4,265,447	)
Balance – June 30, 2021 (unaudited)		3,487,070	$	348		—	$	(4,758,165	)	$	(4,757,817	)
Net income		—		—		—		1,475,730			1,475,730
Balance – September 30, 2021 (unaudited)		3,487,070	$	348		—	$	(3,282,435	)	$	(3,282,087	)

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

BETTER WORLD ACQUISITION CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

	Nine Months Ended September 30,
	For the Three Months Ended March 31,
	2022			2021
	2023			2022
Cash Flows from Operating Activities:
Net income	$	3,407,252		$	2,207,258
Net (loss) income	$	(607,372	)	$	1,647,395
Adjustments to reconcile net income to net cash used in operating activities:
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Interest earned on marketable securities held in Trust Account		(423,734	)		(58,976	)
Interest earned on cash and marketable securities held in Trust Account		(289,547	)		(52,360	)
Unrealized gain on marketable securities held in Trust Account		—			5(17,~~829~~283	)
Change in fair value of convertible promissory note – related party		(213,~~119,960~~200	)		—(337,260	)
Change in fair value of Private Warrant liabilities		(252,~~218,358~~856	)		(31,~~302~~744,~~913~~591	)
Changes in operating assets and liabilities:
Prepaid expenses and other current assets		(1753,~~446~~322	)		4517,~~890~~417
Accounts payable and accrued expenses		~~129~~195,~~889~~564			~~574~~48,~~639~~751
Income taxes payable		2754,~~528~~131			—
Deferred legal fees payable		~~361~~167,~~681~~763			—235,596
Net cash used in operating activities		(~~853~~466,~~148~~727	)		(~~528~~202,~~273~~335	)
Cash Flows from Investing Activities:
Investment of cash into Trust Account		(2360,~~121,860~~000	)		—(1,261,860	)
Cash withdrawn from Trust Account to pay franchise taxes		358,711			—
Cash withdrawn from Trust Account to pay franchise and income taxes		255,823			—
Cash withdrawn from Trust Account in connection with redemption		8612,~~773~~865,~~410~~685			—
Net cash provided by investing activities		85,010,261			—
Net cash provided by (used in) investing activities		12,761,508			(1,261,860	)
Cash Flows from Financing Activities:
Advances from related party		~~100~~710,000			—
Proceeds from promissory note – related party		—			107,639
Proceeds from convertible promissory note – related party		—			1,261,860
Repayment of promissory note – related party		—			(107,639	)
Redemption of common stock		(12,865,685	)		—
Proceeds from convertible promissory note – related party		2,321,860			—
Net cash (used in) provided by financing activities		(12,155,685	)		1,261,860
Redemption of common stock		(86,773,410	)		—
Net Change in Cash		139,096			(202,335	)
Net cash used in financing activities		(84,351,550	)		—
Cash – Beginning of period		2,369			278,197
Net Change in Cash		(194,437	)		(528,273	)
Cash – End of period	$	141,465		$	75,862
Cash – Beginning of period		278,197			1,023,178
Cash – End of period	$	83,760		$	494,905
Non-Cash investing and financing activities:
Conversion of advance to convertible promissory note – related party	$	100,000		$	—
Excise taxes on stock redemption	$	128,657		$	—
Accretion for common stock to redemption amount	$	1585,~~928,271~~694		$	—1,261,860
Promissory note proceeds in excess of initial fair value	$	(338,900	)	$	—
Deferred legal fees payable	$	—		$	235,596

The accompanying notes are an integral part of the unaudited condensed consolidated financial statements.

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

NOTE 1. DESCRIPTION OF ORGANIZATION, BUSINESS OPERATIONS, LIQUIDITY AND GOING CONCERN

Better World Acquisition Corp. (the “Company”) was incorporated in Delaware on August 5, 2020. The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (the “Business Combination”).

Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company is focused on target businesses in the healthy living industries that benefit from strong Environmental, Social and Governance (“ESG”) profiles. The Company is an early stage and emerging growth company and, as such, the Company is subject to all the risks associated with early stage and emerging growth companies.

As of ~~September~~March 3031, ~~2022~~2023, the Company had not ~~commenced~~ commenced any operations. All activity for the period from August 5, 2020 (inception) through ~~September~~March 3031, ~~2022~~2023 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the marketable securities held in the Trust Account (as defined below).

The registration statement for the Company’s Initial Public Offering was declared effective on November 12, 2020. On November 17, 2020, the Company consummated the Initial Public Offering of 11,000,000 units (the “Units” and, with respect to the shares of common stock included in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $110,000,000, which is described in Note 3.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 4,800,000 warrants (the “Private Warrants”) at a price of $1.00 per Private Warrant in a private placement to BWA Holdings LLC (the “Sponsor”) and EarlyBirdCapital, Inc. (“EarlyBirdCapital”), generating gross proceeds of $4,800,000, which is described in Note 4.

Following the closing of the Initial Public Offering on November 17, 2020, an amount of $111,100,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering and the sale of the Private Warrants was placed in a trust account (the “Trust Account”) located in the United States and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund selected by the Company meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account, as described below.

On November 17, 2020, the underwriters notified the Company of their intention to partially exercise their over-allotment option on November 19, 2020. As such, on November 19, 2020, the Company consummated the sale of an additional 1,618,600 Units, at $10.00 per Unit, generating gross proceeds of $16,186,000, and ~~the~~ the sale of an additional 485,580 Private Warrants, at $1.00 per Private Warrant, generating gross proceeds of $485,580. A total of $16,347,860 of the net proceeds was deposited into the Trust Account on November 20, 2020, bringing the aggregate proceeds held in the Trust Account to $127,447,860. On November 9, 2021, in connection with the first extension of the date by which the Company has to consummate a Business Combination, a total of $1,261,860 was deposited into the Trust Account. On February 17, 2022, a total of $1,261,860 was deposited in the Trust Account in connection with the ~~second~~ extension of the date by which the Company has to consummate a Business Combination to May 17, 2022. On May 18, 2022, a total of $500,000 was deposited into the Trust Account in connection with a further extension of the date by which the Company has to consummate a Business Combination to August 17, 2022. On August 17, 2022, November 16, 2022, and December 19, 2022 an aggregate amount of $600,000 was deposited into the Trust Account in connection with a ~~total~~further extension of the date by which the Company has to consummate a Business Combination to February 17, 2023. On January 18, 2023, February 16, 2023 and March 16, 2023, an aggregate amount of $360,000 was deposited into the Trust Account in connection with a further extension of the date by which the Company has to consummate a Business Combination to ~~February~~August 17, 2023.

Transaction costs amounted to $2,880,354 consisting of $2,523,720 of underwriting fees and $356,634 of other offering costs.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Warrants, although substantially all of the net proceeds are intended to be applied generally toward completing a Business Combination. The Company must complete a Business Combination having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding taxes payable on income earned on the Trust Account) at the time of the agreement to enter into an initial Business Combination. The Company will only complete a Business Combination if the post Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully.

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

The Company will provide its holders of the outstanding Public Shares (the “public stockholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The public stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account ($10.4678 per Public Share as of ~~September~~March 3031, ~~2022~~2023 and $10.20 59 per Public Share as of December 31, ~~2021~~2022, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants.

The Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 immediately prior to or upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the shares voted are voted in favor of the Business Combination. If a stockholder vote is not required by law and the Company does not decide to hold a stockholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC containing substantially the same information as would be included in a proxy statement prior to completing a Business Combination. If, however, stockholder approval of the transaction is required by law, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5), Representative Shares (as defined in Note 8) and any Public Shares purchased during or after the Initial Public Offering (a) in favor of approving a Business Combination and (b) not to redeem any shares in connection with a stockholder vote to approve a Business Combination or sell any shares to the Company in a tender offer in connection with a Business Combination. Additionally, each public stockholder may elect to redeem their Public Shares, irrespective of whether they vote for or against the proposed Business Combination.

The Sponsor has agreed (a) to waive its redemption rights with respect to the Founder Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Certificate of Incorporation that would affect a public stockholders’ ability to convert or sell their shares to the Company in connection with a Business Combination or affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination, unless the Company provides the public stockholders with the opportunity to redeem their Public Shares in conjunction with any such amendment.

On November 9, 2021, the Company’s board of directors approved the ~~first~~ extension of the date by which the Company has to consummate a Business Combination from November 17, 2021 to February 17, 2022. In connection with the extension, the Sponsor deposited into the Trust Account $0.10 for each of the 12,618,600 ~~shares~~ shares issued in the Initial Public Offering, for a total of $1,261,860. The Company issued the Sponsor a non-interest bearing unsecured ~~promissory~~ promissory note in the principal amount of $1,261,860 (the “Convertible Promissory Note”), which is payable by the Company upon the earlier of the consummation of the Business Combination or the liquidation of the Company. The Convertible Promissory Note may be repaid in cash or convertible into Private Warrants at a price of $1.00 per Private Warrant. On February 16, 2022, the Company’s board of directors approved the ~~second~~ extension of the date by which the Company has to consummate a Business Combination from February 17, 2022 to May 17, 2022. In connection with the ~~second~~ extension, the Sponsor deposited into the Trust Account an additional $1,261,860 ($0.10 per Public Share) on February 17, 2022, and the Company amended and restated the ~~promissory~~Convertible ~~note~~Promissory Note in its entirety solely to increase the principal amount thereunder from $1,261,860 to $2,523,720. On May 12, 2022, the Company held a special meeting of stockholders inat which a proposal to amend the ~~Company’s~~Amended ~~amended~~ and ~~restated certificate~~Restated Certificate of ~~incorporation~~Incorporation to extend the date by which the Company must consummate a Business Combination from May 17, 2022 to August 17, 2022 ~~(the “Combination Period”)~~ was approved by the stockholders. In connection with this extension, the Company deposited $500,000 into the Trust Account on May 18, 2022. The Company amended and restated the ~~promissory~~Convertible ~~note~~Promissory Note to increase the principal amount ~~thereunder~~ thereunder from $2,523,720 to $3,223,720, which included a drawdown of $500,000 for the extension and a drawdown of $200,000 for working ~~capital~~ capital needs. On August 17, 2022, the Company held a special meeting of stockholders inat which the Company’s stockholders approved a ~~second~~an amendment to the Amended and Restated Certificate of Incorporation to extend the date by which the Company must consummate a Business Combination from August 17, 2022 to February 17, 2023. On August 17, 2022, the Company amended and restated the ~~promissory~~Convertible ~~note~~Promissory Note to increase the principal amount thereunder from $3,223,720 to $3,683,720, which included a drawdown of $360,000 for the extension and $100,000 for working capital purposes. On December 31, 2022, the Company amended and restated the Convertible Promissory Note to increase the principal amount thereunder from $3,683,720 to $4,323,720, which included a drawdown of $240,000 for the extension and $400,000 for working capital purposes. On February 8, 2023, the Company held a special meeting of stockholders at which the Company’s stockholders approved an extension of the date by which the Company must consummate a Business Combination from February 17, 2023 to August 17, 2023.

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay taxes, divided by the number of then outstanding Public Shares, which redemption will completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

IfThe ~~the~~Sponsor ~~Company~~has isagreed ~~unable~~ to ~~complete~~waive aits ~~Business~~liquidation ~~Combination~~rights ~~within~~with respect to the ~~Combination~~Founder ~~Period,~~Shares if the Company ~~will~~fails ~~(i)~~to ~~cease~~complete ~~all~~a ~~operations~~Business ~~except~~Combination ~~for~~within the ~~purpose~~Combination ofPeriod. ~~winding up~~However, if ~~(ii)~~the asSponsor ~~promptly as~~acquires ~~reasonably~~Public ~~possible~~Shares ~~but~~in ~~not~~or ~~more~~after ~~than~~the ~~ten~~Initial ~~business~~Public ~~days thereafter~~Offering, ~~redeem~~such ~~the~~ Public Shares, atwill abe ~~per-share~~entitled ~~price,~~to ~~payable~~liquidating ~~in cash,~~distributions ~~equal~~from to the ~~aggregate amount then on deposit in the~~ Trust Account ~~including~~if ~~interest earned on~~ the ~~funds~~Company ~~held~~fails into ~~the~~complete ~~Trust~~a ~~Account~~Business ~~and not~~Combination ~~previously~~within ~~released to~~ the ~~Company~~Combination toPeriod. ~~pay~~In ~~taxes, divided by~~ the ~~number~~event of ~~then~~such ~~outstanding Public Shares~~distribution, ~~which redemption will completely~~ ~~extinguish~~it ~~public~~is ~~stockholders’~~possible ~~rights~~that ~~as stockholders (including~~ the ~~right~~per toshare ~~receive~~value ~~further~~of ~~liquidating~~the ~~distributions,~~assets ifremaining ~~any), subject~~available tofor ~~applicable~~distribution ~~law,~~will ~~and~~be ~~(iii)~~less asthan ~~promptly as reasonably possible following such redemption, subject to~~ the ~~approval~~amount of ~~the~~funds ~~Company’s~~initially ~~remaining~~deposited ~~stockholders~~into ~~and~~ the ~~Company’s~~Trust ~~board~~Account of(initially ~~directors,~~$10.10 ~~dissolve~~per ~~and liquidate~~share, ~~subject~~subsequently inincreased ~~each case~~ to ~~the~~approximately ~~Company’s obligations~~$10.60 ~~under~~following ~~Delaware law to provide for claims of creditors and~~ the ~~requirements~~extension ofin February ~~other applicable law~~2023).

~~The~~In order to protect the amounts held in the Trust Account, the Sponsor has agreed to ~~waive~~be ~~its~~liable ~~liquidation rights~~to ~~with~~the ~~respect~~Company if and to the ~~Founder~~extent ~~Shares~~any ifclaims ~~the~~by ~~Company~~a ~~fails~~vendor for services rendered or products sold to ~~complete~~the Company, or a ~~Business~~prospective ~~Combination~~target ~~within~~business with which the ~~Combination~~Company ~~Period.~~has ~~However~~discussed entering into a transaction agreement, reduce ifthe amount of funds in the ~~Sponsor~~Trust ~~acquires~~Account to below $10.10 per Public ~~Shares~~Share, inexcept oras ~~after~~to any claims by a third party who executed a valid and enforceable agreement with the ~~Initial~~Company ~~Public~~waiving ~~Offering~~any right, ~~such~~title, ~~Public~~interest ~~Shares~~or ~~will~~claim beof ~~entitled~~any kind they may have in or to ~~liquidating~~any ~~distributions~~monies held ~~from~~in the Trust Account ifand except as to any claims under the Company’s ~~fails~~indemnity toof ~~complete~~the aunderwriters ~~Business~~of ~~Combination~~Initial ~~within~~Public ~~the~~Offering ~~Combination~~against certain ~~Period.~~liabilities, Inincluding liabilities under the ~~event~~Securities Act of ~~such~~1933, ~~distribution~~as amended (the “Securities Act”). Moreover, itin isthe ~~possible~~event that an executed waiver is deemed to be unenforceable against a third party, the ~~per~~Sponsor ~~share~~will ~~value~~not ofbe responsible to the ~~assets~~extent of ~~remaining~~any ~~available~~liability for ~~distribution~~such third-party claims. The Company will beseek ~~less~~to ~~than~~reduce the ~~amount~~possibility ofthat ~~funds~~the ~~initially deposited~~Sponsor ~~into~~will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (~~initially~~except ~~$10.10~~the ~~per~~Company’s ~~share~~independent registered public accounting firm), ~~subsequently~~prospective ~~increased~~target tobusinesses ~~$10.46~~or ~~per~~other ~~share~~entities aswith ofwhich ~~September~~the 30Company does business, ~~2022~~execute ~~following~~agreements ~~extensions)~~with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.

InBusiness ~~order~~Combination to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below $10.10 per Public Share, except as to any claims by a third party who executed a valid and enforceable agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account and except as to any claims under the Company’s indemnity of the underwriters of Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the insiders will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the insiders will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (except the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.Agreement

~~Risks~~On December 9, 2022, the Company announced the execution of a definitive business combination agreement (the “Business Combination Agreement”) with Heritage Distilling Holding Company, Inc., a Delaware corporation (together with its successors, “Heritage”), Heritage Distilling Group, Inc. (formerly HDH Newco, Inc.), a Delaware corporation and ~~Uncertainties~~a wholly owned subsidiary of Better World (“Pubco” ), BWA Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Pubco, HD Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Pubco, the Sponsor in the capacity as the representative for the stockholders of the Company and Pubco (other than the former Heritage stockholders), and (vii) Justin Stiefel, in the capacity as the representative for certain security holders of Heritage, for a proposed business combination among the parties.

Management continues to evaluate the impact of the COVID-19 pandemic and the military conflict in the Ukraine and has concluded that while it is reasonably possible that the virus and the military conflict could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impacts are not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Inflation Reduction Act of 2022

Any redemption or other repurchase that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance from the U.S. Department of the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination.

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

On May 18, 2023, the Company notified Heritage of the termination of the Business Combination Agreement pursuant to Section 8.1(b) thereof, effective as of the date of such notice. As a result of the Termination, the Business Combination Agreement is of no further force and effect, with the exception of the specified provisions in Section 8.2 of the Business Combination Agreement, which shall survive the termination of the Business Combination Agreement and remain in full force and effect in accordance with their respective terms.

Risks and Uncertainties

Management continues to evaluate the impact of the COVID-19 pandemic and the military conflict in Ukraine and has concluded that while it is reasonably possible that the virus and the military conflict could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impacts are not readily determinable as of the date of these condensed consolidated financial statements. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

Liquidity and Going Concern

As of ~~September~~March 3031, ~~2022~~2023, the Company had $83141,~~760~~465 in its operating bank accounts and $4432,~~203~~224,~~481~~663 in securities held in the Trust Account to be used for a Business Combination or to repurchase or redeem its common stock in connection therewith. As of ~~September~~March 3031, ~~2022~~2023, $~~145~~358,~~311~~699 of the amount on deposit in the Trust Account ~~represented~~ represented accrued interest income, which can be withdrawn to pay the Company’s tax obligations.

On May 13, 2022, July 1, 2022, ~~and~~ August 16, 2022 and February 14, 2023, the Company withdrew $178,564, $66,751, ~~and~~ $113,396 and $255,823, respectively, of accrued interest from the Trust Account to pay certain ~~tax~~ tax obligations.

On November 9, 2021, the Company issued the Convertible Promissory Note in the principal amount of $1,261,860 to the Sponsor in connection with the Extension (See Note 5). On February 17, 2022, April 14, 2022, May 18, 2022, August 17, 2022 and December 31, 2022 the Company amended and restated the Convertible Promissory Note to increase the principal amount thereunder from $1,261,860 to $4,323,720.

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

(Unaudited)

On May 12, 2022 and August 15, 2022, the Company held special meetings of stockholders at which proposals to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company must consummate a Business Combination from May 17, 2022 to August 17, 2022 and from August 17, 2022 to February 17, 2023, were approved, respectively. In connection with the May 12, 2022 and the August 15, 2022 meetings, stockholders holding 5,586,910 shares and 2,818,237 shares, respectively, exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $57.5 million and $29.2 million, respectively, was released from the Trust Account. On February 8, 2023, the Company held a special meeting of stockholders at which a third amendment to the Company’s amended and restated certificate of incorporation to extend the date by which the Company must consummate its initial business combination from February 17, 2023 to August 17, 2023 was approved. In connection with the meeting stockholders holding 1,213,453 shares of the Company’s common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account. As a result, approximately $12.9 million was released from the Trust Account.

Until the consummation of a Business Combination, the Company will use the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination.

~~The~~In ~~Company~~connection ~~expects~~with itthe ~~will~~Company’s ~~need to raise additional~~assessment ~~capital~~of ~~through~~going ~~loans~~concern orconsiderations ~~additional~~in ~~investments~~accordance ~~from~~with ~~its~~Financial ~~Sponsor,~~Accounting ~~stockholders,~~Standard ~~officers,~~Board ~~directors,~~(“FASB”) orAccounting ~~third~~Standards ~~parties. The Company’s~~Update ~~officers,~~(“ASU”) ~~directors and the Sponsor may~~2014-15, ~~but~~“Disclosures ~~are~~of ~~not~~Uncertainties ~~obligated~~about ~~to,~~an ~~loan~~Entity’s ~~the~~Ability ~~Company funds, from time~~ to ~~time~~Continue oras ata ~~any~~Going ~~time~~Concern, ~~in whatever~~” ~~amount~~the ~~they~~Company ~~deem~~has ~~reasonable~~until inAugust ~~their sole discretion~~17, 2023 to ~~meet~~consummate ~~the~~a ~~Company’s~~Business ~~working~~Combination. ~~capital~~It ~~needs.~~is ~~Accordingly,~~uncertain that the Company ~~may not~~will be able to ~~obtain~~consummate a ~~additional~~Business ~~financing~~Combination by this time. If ~~the~~a ~~Company~~Business Combination is ~~unable~~not toconsummated ~~raise~~by ~~additional~~this ~~capital,~~date itand ~~may~~another beextension ~~required~~has tonot ~~take~~been ~~additional~~requested ~~measures~~by tothe ~~conserve~~Sponsor ~~liquidity,~~and ~~which~~approved ~~could~~by ~~include,~~the ~~but~~Company’s ~~not~~stockholders, ~~necessarily~~there will be ~~limited~~a ~~to,~~mandatory ~~curtailing~~liquidation ~~operations,~~and ~~suspending~~subsequent ~~the~~dissolution ~~pursuit~~ of athe Company. ~~potential~~Management ~~transaction,~~has ~~and~~determined ~~reducing~~that ~~overhead~~the ~~expenses.~~liquidity ~~The~~condition ~~Company~~and ~~cannot~~the ~~provide~~mandatory ~~any~~liquidation ~~assurance~~and ~~that~~potential ~~new~~subsequent ~~financing~~dissolution ~~will~~raises substantial bedoubt ~~available to~~about itthe onCompany’s ~~commercially~~ability ~~acceptable~~to ~~terms,~~continue ifas ata ~~all~~going concern.

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company has until February 17, 2023 to consummate a Business Combination. It is uncertain that the Company will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date and an extension has not been requested by the Sponsor and approved by the Company’s stockholders, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and the mandatory liquidation and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after ~~February~~August 17, 2023. The Company intends to ~~continue to search for and seek to~~ complete a a Business Combination before the mandatory liquidation date. ~~The Company is within 12 months of its mandatory liquidation date as of the time of filing of this Quarterly Report on Form 10-Q.~~

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed ~~financial~~consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.

The accompanying unaudited condensed ~~financial~~consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the period ended December 31, ~~2021,~~ 2022, as filed with the SEC on March 31, ~~2022~~2023. The interim results for the three ~~and nine~~ months ended ~~September~~March 3031, ~~2022~~2023 are not necessarily ~~indicative~~ indicative of the results to be expected for the year ending December 31, ~~2022~~2023 or for any future periods.

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

~~Reclassification~~Principles of ~~Prior Year Presentation~~Consolidation

~~Certain~~The ~~prior~~accompanying ~~year~~consolidated ~~amounts~~financial ~~have been reclassified~~statements toinclude ~~conform to~~ the ~~current~~accounts ~~period presentation. These reclassifications had no effect on the reported results~~ of ~~operations. An adjustment has been made to~~ the ~~balance~~Company ~~sheet~~and ~~for~~its ~~December~~wholly ~~31,~~owned ~~2021~~subsidiary. toAll ~~reclassify~~significant ~~the~~balances ~~deferred~~and ~~legal~~transactions ~~fees~~have ~~balance~~been ~~from~~eliminated ~~accrued expenses to a separate~~in ~~deferred legal fees line~~consolidation.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the ~~near~~ near term due to one or more future confirming events. Two of the more significant accounting estimates included in these condensed consolidated financial statements is the determination of the fair value of the warrant liabilities as well as the fair value of the convertible promissory note. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ ~~significantly~~ significantly from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022.

910

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

Cash and Marketable Securities Held in Trust Account

At ~~September~~March 3031, ~~2022,~~2023 ~~substantially~~and ~~all of the assets held in the Trust Account were held in money market funds which are invested primarily in U.S Treasury securities. At~~ December 31, ~~2021~~2022, ~~substantially~~ all of the assets held in the Trust Account were held in ~~U.S.~~a ~~Treasury~~cash ~~Securities.~~demand ~~All of the Company’s investments held in the Trust Account are classified as trading securities~~account. ~~Trading securities are presented on the balance sheets at fair value at the end of each reporting period.~~ Gains and losses resulting from the change in fair value of investments held in the Trust Account are included in interest earned on cash and marketable securities held in the Trust Account in the accompanying condensed consolidated statements of operations. ~~The~~As ~~estimated fair values~~ of ~~investments~~March ~~held in the Trust Account are determined using available market information. As of September 30~~31, ~~2022~~2023, the Company has withdrawn $~~358~~614,~~711~~534 of interest income from the Trust Account to pay certain tax obligations.

Common Stock Subject to Possible Redemption

The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the ~~control~~ control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ~~as of September 30, 2022 and December 31, 2021, respectively,~~ common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed consolidated balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.

At ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, the common stock reflected in the condensed consolidated balance sheets are reconciled in the following table:

Gross proceeds	$	126,186,000
Less:
Common stock issuance costs		(2,868,790	)
Redemption of shares		(86,773,410	)
Plus:
Accretion of carrying value to redemption value		58,~~392~~088,~~510~~614
Common stock subject to possible redemption – December 31, 2021	$	128,709,720
Common stock subject to possible redemption – December 31, 2022		44,632,414
Less:
Redemption of shares		(8612,~~773~~865,~~410~~685	)
Plus:
Accretion of carrying value to redemption value		2585,~~267,171~~694
Common stock subject to possible redemption – September 30, 2022	$	44,203,481
Common stock subject to possible redemption – March 31, 2023	$	32,352,423

Warrant Liabilities

The Company accounts for the Private Warrants in accordance with the guidance contained in ASC 815-40-15-7D and 7F under which the Private Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Private Warrants as liabilities at their fair ~~value~~ value and adjusts the Private Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statements of operations. The Private Warrants for periods where no observable traded price was available are valued using a binomial lattice simulation model.

10This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our condensed consolidated statements of operations. The Private Warrants for periods where no observable traded price was available are valued using a binomial lattice simulation model.

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

Convertible Promissory Note – Related Party

The Company accounts for its convertible promissory note under ASC 815, Derivatives and Hedging (“ASC 815”). Under 815-15-25, the election can be at the inception of a financial ~~instrument~~ instrument to account for the instrument under the fair value option under ASC 825. The Company has made such election for its convertible ~~promissory~~ promissory note. Using fair value option, the convertible promissory note is required to be recorded at its initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the note are recognized as non-cash change in the fair value of the convertible promissory note in the condensed consolidated statements of operations. The fair value of the option to convert the convertible promissory note into Private Warrants was valued by utilizing a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology.

Income Taxes

The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740, Income Taxes, requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the unaudited condensed consolidated financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. As of ~~September 30~~March 31, ~~2022~~2023 and December 31, ~~2021~~ 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it.

The Company’s effective tax rate was 2 (9.6878% ) and 0.00% for the three months ended ~~September~~March 3031, ~~2022~~2023 and ~~2021, respectively, and 0.80% and 0.00% for the nine months ended September 30,~~ 2022 ~~and 2021~~, respectively. The effective tax rate differs from the statutory tax rate of 21% for the three months ~~and nine months~~ ended ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, due to changes in fair value in warrant liability, changes in the fair value of the convertible promissory note, transaction costs associated with merger and the valuation allowance on the deferred tax assets.

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition.

While ASC 740 identifies usage of an effective annual tax rate for purposes of an interim provision, it does allow for estimating individual elements in the current period if they ~~are~~ are significant, unusual, or infrequent. Computing the effective tax rate for the Company is complicated due to the potential impact of the timing of any Business Combination expenses and the actual interest income that will be recognized during the year. The Company has taken a position as to the calculation of income tax expense in a current period based on ASC 740-270-25-3 which states, “If an entity is unable to estimate part of its ordinary income (or loss) or the related tax (benefit) but is otherwise able to make a reasonable estimate, the tax (or benefit) applicable to the item that cannot be estimated shall be reported in the interim period in which the item is reported.” The Company believes its calculation to be a reliable estimate and allows it to properly take into account the usual elements that can impact its annualized book income and its impact on the effective tax rate. As such, the Company is computing its taxable income ~~(loss)~~ and associated income tax provision based on actual results through ~~September~~March 3031, ~~2022~~2023.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022. The Company is currently not aware of any issues under review that could ~~result~~ result in significant payments, accruals or material deviation from its position.

The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Net (Loss) Income Per Common Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net (loss) income per common share is computed by dividing net ~~income~~(loss) income by the weighted average number of common shares outstanding for the period. Accretion associated with the redeemable shares of ~~common~~ common stock is excluded from (loss) income per common share as the redemption value approximates fair value.

The calculation of diluted (loss) income per share ~~does~~ does not consider the effect of the warrants issued in connection with the (i) Initial Public Offering, and (ii) the private placement ~~since~~ since the exercise of the warrants is contingent upon the occurrence of future events. The warrants are exercisable to purchase 17,904,180 shares of common stock in the aggregate. As of ~~September~~March 3031, ~~2022~~2023 and ~~2021~~2022, the Company did not have any dilutive securities or other ~~contracts~~ contracts that could, potentially, be exercised or converted into common stock and then participate in the earnings of the Company. As a result, diluted net (loss) income per common share is the same as basic net (loss) income per common share for the periods presented.

1112

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

Reconciliation of Net (Loss) Income per ~~Common~~ Common Share

The Company’s net income (loss) is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted net (loss) income per common share is calculated as as follows:

	Three Months Ended September 30, 2022						Three Months Ended September 30, 2021				Nine Months Ended September 30, 2022				Nine Months Ended September 30, 2021
	For the Three Months Ended March 31,
	Redeemable Common Stock			Non-Redeemable Common Stock			Redeemable Common Stock		Non-Redeemable Common Stock		Redeemable Common Stock		Non-Redeemable Common Stock		Redeemable Common Stock		Non-Redeemable Common Stock
	2023						2022
Basic and diluted net income per common share
	Redeemable Common Stock			Non- Redeemable Common Stock			Redeemable Common Stock		Non- Redeemable Common Stock
Numerator:
Basic and diluted net (loss) income per common share
Allocation of net income, as adjusted	$	519,931		$	324,223		$	1,156,217		319,513	$	2,475,778	$	931,474	$	1,729,360	$	477,898
Numerator:
Denominator:
Allocation of net (loss) income, as adjusted	$	(308,809	)	$	(298,563	)	$	1,290,714	$	356,681
Basic and diluted weighted average shares outstanding		5,591,938			3,487,070			12,618,600		3,487,070		9,268,327		3,487,070		12,618,600		3,487,070
Denominator:
Basic and diluted net income per common share	$	0.09		$	0.09		$	0.09	$	0.09	$	0.27	$	0.27	$	0.14	$	0.14
Basic and diluted weighted average stock outstanding		3,606,727			3,487,070			12,618,600		3,487,070
Basic and diluted net (loss) income per common share	$	(0.09	)	$	(0.09	)	$	0.10	$	0.10

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times may exceed the Federal Deposit Insurance Corporation maximum coverage of $250,000. The Company has not experienced losses on these accounts.

Fair Value of Financial Instruments

The fair value of the Company’s assets ~~and~~ and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying condensed consolidated balance sheets, primarily due to their short-term nature, except for warrant ~~liabilities~~ liabilities (see Note 9).

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements).

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

1213

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

Recent Accounting Standards

In August 2020, the ~~Financial Accounting Standards Board (“~~FASB”) issued ~~Accounting Standards Update (“~~ASU”) No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company assessed the potential impact of ASU 2020-06 and determined that it would not have aan ~~material~~ impact on the condensed consolidated financial statements as presented.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed consolidated financial statements.

NOTE 3. PUBLIC OFFERING

Pursuant to the Initial Public Offering, the Company sold 11,000,000 Units at a price of $10.00 per Unit. Each Unit consists of one share of common stock and one redeemable warrant (“Public Warrant”). In connection with the underwriters’ partial exercise of the over-allotment option on November 19, 2020, the Company sold an additional 1,618,600 Units, at a purchase price of $10.00 per Unit. Each Public Warrant entitles the holder to purchase one share of common stock at an exercise price of $11.50 per share (see Note 8).

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering, the Sponsor and EarlyBirdCapital purchased an aggregate of 4,800,000 Private Warrants at a price of $1.00 per Private Warrant for an aggregate purchase price of $4,800,000. The Sponsor purchased 3,975,000 Private Warrants and EarlyBirdCapital purchased 825,000 Private Warrants. In connection with the underwriters’ partial exercise of the over-allotment option on November 19, 2020, the Sponsor and EarlyBirdCapital purchased an additional 485,580 Private Warrants, at a purchase price of $1.00 per Private Warrant, for an aggregate purchase price of $485,580. Each Private Warrant entitles the holder to purchase one share of common stock at a price of $11.50 per full share, subject to adjustment (see Note 8). The proceeds from the Private Warrants were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Warrants will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On August 5, 2020, the Sponsor paid $25,000 to cover certain offering costs of the Company in consideration for 3,593,750 shares of common stock (the “Founder Shares”). On November 9, 2020, the Sponsor returned to the Company for cancellation, at no cost, an aggregate of 718,750 Founder Shares, resulting in an aggregate of 2,875,000 Founder Shares outstanding and held by the Sponsor. On November 12, 2020, the Company effected a stock dividend of 0.1 shares for each share of common stock outstanding, resulting in an aggregate of 3,162,500 Founder Shares outstanding and held by by the Sponsor. The Founder Shares included, after giving retroactive effect to the share surrender and stock dividend, an aggregate of up to 412,500 shares subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part, so that the Sponsor would collectively own 20% of the Company’s issued and outstanding shares after the Initial Public ~~Offering~~ Offering (assuming the Sponsor did not purchase any Public Shares in the Initial Public Offering). In connection with the underwriters’ ~~partial~~ partial exercise of the over-allotment option and the forfeiture of the remaining over-allotment option, 7,850 Founder Shares were forfeited, and 404,650 Founder Shares are no longer subject to forfeiture resulting in an aggregate of 3,154,650 Founder Shares outstanding at ~~September~~March 3031, 2023 and December 31, 2022.

The Sponsor has agreed, subject to certain limited exceptions, not to transfer, assign or sell any of the Founder Shares until (1) with respect to 50% of the Founder Shares, the earlier of one year after the completion of a Business Combination and the date on which the closing price of the common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after a Business Combination and (2) with respect to the remaining 50% of the Founder Shares, one year after the completion of a Business Combination, or earlier, in either case, if, subsequent to a Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.

1314

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

Due from Sponsor

At the closing of the Initial Public Offering on November 17, 2020, an aggregate amount of $25,038 was due to the Company. Such amount was paid by the Company to the Sponsor and was included in the prepaid expenses and other current assets on the balance sheet at December 31, 2020. No balance remains outstanding as of September 30, 2022.

Administrative Support Agreement

The Company has agreed, commencing on November 12, 2020 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Company’s management a total of $10,000 per month for office space, utilities and secretarial support. For the three ~~and nine~~ months ended ~~September~~March 3031, 2023 and 2022, the Company incurred $30,000 and $9030,000, ~~respectively,~~ in fees for these services, respectively, of which such amounts are included in accrued expenses in the accompanying condensed consolidated balance sheets. ~~For the three and nine months ended September 30, 2021, the Company incurred and paid $30,000 and $90,000, respectively, in fees for these services.~~

Promissory Note — Related Party

On August 5, 2020, the Company issued an unsecured promissory note to the Sponsor (the “Promissory Note”), pursuant to which the Company could borrow up to an aggregate principal amount of $300,000. The Promissory Note was non-interest bearing and payable on the earlier of (i) March 31, 2021, (ii) the consummation of the Initial Public Offering or (iii) the date on which the Company determined not to proceed with the Initial Public Offering. The outstanding balance under the Promissory Note was repaid subsequent to the Initial Public Offering. As of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, respectively, no balance is outstanding under the Promissory Note. Borrowings under the Promissory Note are no longer available.

Related Party Loans

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or certain of the Company’s officers and directors or their affiliates may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). Each loan would be evidenced by promissory note. The notes may be repaid upon completion of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of notes may be converted upon completion of a Business Combination into warrants at a price of $1.00 per warrant. Such warrants would be identical to the Private Warrants. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.

On April 14, 2022 the Sponsor advanced to the Company $100,000 to be used for working capital purposes. On August 17, 2022, the Company transferred the advance from the Sponsor to the second amended and restated promissory note (see Convertible Promissory Note – Related Party below). On October 13, 2022, ~~the~~ the Sponsor advanced to the Company $200,000 to be used for working capital purposes. On December 31, 2022, the Company converted the advance from the Sponsor to the third amended and restated promissory note (see Convertible Promissory Note – Related Party below). On January 31, 2023, February 28, 2023, March 29, 2023, and March 31, 2023, the Sponsor advanced to the Company an aggregate amount of $710,000.

~~Related~~Convertible ~~Party~~Promissory ~~Extension~~Note ~~Loans~~– Related Party

As discussed in Note 1, the Company previously extended the period of time to consummate a Business Combination ~~two times, each by an additional three months (~~to May 17, 2022 ~~to complete a Business Combination)~~. In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees deposited into the Trust Account $1,261,860 ($0.1020 per Public Share), on or prior to the date of the applicable ~~deadline,~~ ~~for each three-month extension~~deadline. Payments were made in the form of a non-interest bearing, unsecured promissory note to be paid upon consummation of a Business Combination, or, at the ~~relevant insider~~Sponsor’s discretion, converted upon consummation of a Business Combination into additional Private Warrants at a price of $1.00 per Private Warrant. The Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete a Business Combination. On May 12, 2022, the Company held a special meeting of stockholders at which a proposal to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company must consummate a Business Combination from May 17, 2022 to August 17, 2022 was approved by stockholders. In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees deposited into the Trust Account $500,000. On August 15, 2022, the Company held a special meeting of stockholders at which a proposal to amend the Company’s amended and restated certificate of incorporation, as amended to extend the date by which the Company must consummate a Business Combination from August 17, 2022 to February 17, 2023 was approved by stockholders. In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliates or designees deposited into the Trust Account $360,000. On November 16, 2022 and December 19, 2022, the Company deposited an aggregate of $240,000 into the Trust Account in connection with the extension.

1415

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

On November 9, 2021, the Company issued the Convertible Promissory Note in the principal amount of $1,261,860 to the Sponsor in connection with the Extension. On August 15, 2022, the Company held a special meeting of stockholders at which a proposal to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company must consummate a Business Combination from August 17, 2022 to February 17, 2023 was approved by stockholders. On February 17, 2022, April 14, 2022, May 18, 2022, August 17, 2022 and December 31, 2022 the Company amended and restated the Convertible Promissory Note –to ~~Related~~increase the principal amount thereunder from $1,261,860 to $4,323,720. The Convertible Promissory Note bears no interest ~~Party~~and is due and payable upon the earlier to occur of (i) the date on which the Company’s Business Combination is consummated and (ii) the liquidation of the Company on or before February 17, 2023 or such later liquidation date as may be approved by the Company’s stockholders. At the election of the Sponsor, up to $1,500,000 of the unpaid principal amount of the Convertible Promissory Note may be converted into warrants of the Company, each warrant exercisable for one share of common stock of the Company upon the consummation of its Business Combination, equal to: (x) the portion of the principal amount of the Convertible Promissory Note being converted, divided by (y) $1.00, rounded up to the nearest whole number of warrants. As of March 31, 2023 and December 31, 2022, there was $4,323,720 and $4,323,720 outstanding under the Convertible Promissory Note, respectively. The Convertible Promissory Note was valued using the fair value method. The fair value of the Convertible Promissory Note as of March 31, 2023 and December 31, 2022, was $914,700 and $901,500, respectively, which resulted in a change in fair value of the convertible promissory note of $13,200 and $2,772,360 which was recorded in the condensed consolidated statements of operations for the period ended March 31, 2023 and December 31, 2022, respectively (see Note 9).

On November 9, 2021, the Company issued a promissory note in the principal amount of $1,261,860 to the Sponsor in connection with the Extension (“Convertible Promissory Note”) (as defined below). On February 17, 2022, April 14, 2022 and May 18, 2022, the Company amended and restated the Convertible Promissory Note to increase the principal amount thereunder from $1,261,860 to $3,223,720. On August 17, 2022 the Company amended and restated the Convertible Promissory Note to increase the principal amount thereunder from $3,223,720 to $3,683,720, which included $100,000 advanced by the Sponsor to the Company on April 14, 2022 and the payment of $360,000 for the extension from August 17, 2022 to November 17, 2022. The Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which the Company’s Business Combination is consummated and (ii) the liquidation of the Company on or before February 17, 2023 or such later liquidation date as may be approved by the Company’s stockholders. On August 15, 2022, the Company held a special meeting of stockholders in which a proposal to amend the Company’s amended and restated certificate of incorporation to extend the date by which the Company must consummate a Business Combination from August 17, 2022 to February 17, 2023 was approved by stockholders. At the election of the Sponsor, up to $1,500,000 of the unpaid principal amount of the Note may be converted into warrants of the Company, each warrant exercisable for one share of common stock of the Company upon the consummation of its Business Combination, equal to: (x) the portion of the principal amount of the Note being converted, divided by (y) $1.00, rounded up to the nearest whole number of warrants. As of September 30, 2022, there was a $3,683,720 balance outstanding under the Convertible Promissory Note. The Convertible Promissory Note was valued using the fair value method. The fair value of the note as of September 30, 2022, was $913,900, which resulted in a change in fair value of the convertible promissory note of $1,113,700 and $2,119,960 which was recorded in the statements of operations for the three and nine months ended September 30, 2022, respectively (see Note 9).

NOTE 6. COMMITMENTS AND CONTINGENCIES

Registration Rights

Pursuant to a registration rights agreement entered into on November 12, 2020, the holders of the Founder Shares and Representative Shares (as defined in Notes 5 and 8, respectively), as well as the holders of the Private Warrants (and underlying securities) and any warrants issued in payment of Working Capital Loans made to Company (and underlying securities) will be entitled to registration rights. The holders of a majority of these securities are entitled to make up to two demands that the Company register such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Representative Shares, Private Warrants and warrants issued in payment of working capital loans made to the Company (or underlying securities) can elect to exercise these registration rights at any time after the Company consummates a Business Combination. Notwithstanding anything to the contrary, EarlyBirdCapital may only make a demand on one occasion and only during the five-year period beginning on the effective date of the registration statement of which this prospectus forms a part. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to consummation of a Business Combination; provided, however, that EarlyBirdCapital may participate in a “piggy-back” registration only during the seven-year period beginning on the effective date of the registration statement of which this prospectus forms a part. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 1,650,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On November 19, 2020, the underwriters partially exercised their over-allotment option to purchase an additional 1,618,600 Units at $10.00 per Unit and forfeited the remaining over-allotment option.

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

SEPTEMBER 30, 2022

(Unaudited)

Business Combination Marketing Agreement

The Company has engaged EarlyBirdCapital as an advisor in connection with a Business Combination to assist the Company in holding meetings with its stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with a Business Combination, assist the Company in obtaining stockholder approval for the Business Combination and assist the Company with its press releases and public filings in connection with the Business Combination. The Company will pay EarlyBirdCapital a cash fee for such services upon the consummation of a Business Combination in an amount equal to 3.5% of the gross proceeds of the Initial Public Offering, or $4,416,510, (exclusive of any applicable finders’ fees which might become payable); provided that up to 30% of the fee may be allocated at the Company’s sole discretion to other FINRA members that assist the Company in identifying and consummating a Business Combination.

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

(Unaudited)

Additionally, the Company will pay EarlyBirdCapital a cash fee equal to 1.0% of the total consideration payable in a Business Combination if EarlyBirdCapital introduces the Company to the target business with which the Company completes a Business Combination.

Legal Fee Agreements

The Company has engaged various law firms to provide legal due diligence services and business combination services related to potential target companies. All fees and expenses related to the various engagements will be deferred and are to be paid fully upon the closing of any Business Combination. The law firms will not be entitled to any contingent fees or expense reimbursement if the Company does not consummate a Business Combination within its deadline. Deferred fees of $1,~~371~~821,~~549~~ 825 and $1,~~009~~654,~~868~~062 related to these legal services have been accrued as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, respectively.

~~Trust~~ Extension

On February 16, 2022, the Company issued a press release announcing that its Sponsor has requested that the Company extend the date by which the Company has to consummate a Business ~~Combination~~ Combination from February 17, 2022 to May 17, 2022 (the “Extension”). ~~The Extension is the second of two three-month extensions permitted under the Company’s governing documents and provides the Company with additional time to complete its Business Combination.~~ On February 18, 2022, the Company issued a press release announcing that the Sponsor had deposited an additional $1,261,860 (representing $0.10 per ~~public~~Public ~~share~~Share) into the Trust Account for its public stockholders. On May 12, 2022, the Company held a special meeting of stockholders in at which a proposal to amend the ~~Company’s~~Amended ~~amended~~ and ~~restated~~Restated ~~certificate~~ Certificate of ~~incorporation~~Incorporation to extend the date by which the Company must consummate a Business Combination from May 17, 2022 to August 17, 2022 was approved by the stockholders. In connection with this extension, the Company deposited $500,000 into the Trust Account on May 18, 2022. In connection with the extension amendment, stockholders holding approximately 5,586,910 shares of the Company’s redeemable common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account at a redemption price of approximately $10.30 per share. On August 15, 2022, the Company held a special meeting of stockholders inat which a proposal to amend the ~~Company’s~~Amended ~~amended~~ and Restated ~~restated~~Certificate ~~certificate~~ of ~~incorporation~~ Incorporation to extend the date by which the Company must consummate a Business Combination from August 17, 2022 to February 17, 2023 was approved by the stockholders. In connection with this extension, the Company deposited $360,000 into the Trust Account on August 17, 2022, and stockholders holding approximately 2,818,237 shares of the Company’s redeemable common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account at a redemption price of approximately $10.37 per Inshare. On November 16, 2022 and December 19, 2022, the Company deposited an aggregate amount of $240,000 into the Trust Account in connection with the extension. ~~amendment~~On February 8, 2023, the Company held a special meeting of stockholders ~~holding~~at ~~approximately~~which 2a proposal to amend the Amended and Restated Certificate of Incorporation to extend the date by which the Company must consummate a Business Combination from February 17,~~818~~ 2023 to August 17,~~237~~ 2023 was approved by the stockholders. In connection with the extension, stockholders holding 1,213,453 shares of the Company’s redeemable common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account at a redemption price of approximately $10.3760 per share. On January 18, 2023, February 22, 2023, and March 21, 2023, the Company deposited an aggregate amount of $360,000 into the Trust Account in connection with the extension.

On November 16, 2021, the Company ~~had previously~~ issued ~~a promissory note (~~the “Convertible Promissory Note”) in the principal amount of $1,261,860 to the ~~Company’s~~ Sponsor. On February 17, 2022, April 14, 2022, May 18, 2022, ~~and~~ August 17, 2022 and December 31, 2022, the Company amended and restated the Convertible Promissory Note in its entirety to increase the principal ~~amount~~ amount thereunder from $1,~~262~~261,860 to $34,~~683~~323,720.

Business Combination Agreement

On December 9, 2022, the Company entered into the Business Combination Agreement with Heritage, Pubco, SPAC Merger Sub, Company Merger Sub, the Sponsor in the capacity as the representative for the stockholders of the Company and Pubco (other than the former Heritage stockholders), and (vii) Justin Stiefel, in the capacity as the representative for certain security holders of Heritage for a proposed business combination among the parties.

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

MARCH 31, 2023

(Unaudited)

Inflation Reduction Act of 2022

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury Department”) has authority to promulgate regulations and provide other guidance regarding the excise tax. In December 2022, the Treasury Department issued Notice 2023-2, indicating its intention to propose such regulations and issuing certain interim rules on which taxpayers may rely. Under the interim rules, liquidating distributions made by publicly traded domestic corporations are exempt from the excise tax. In addition, any redemptions that occur in the same taxable year as a liquidation is completed will also be exempt from such tax. Accordingly, redemptions of Public Shares in connection with a Business Combination, extension vote or otherwise (a “Redemption Event”) may subject the Company to the excise tax, unless one of the two exceptions above apply.

The extent to which the Company would be subject to the excise tax in connection with a Redemption Event would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Redemption Event, (ii) the nature and amount of any “PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Redemption Event but issued within the same taxable year of a Business Combination), (iii) if we fail to timely consummate a Business Combination and liquidate in a taxable year following a Redemption Event and (iv) the content of any proposed or final regulations and other guidance from the Treasury Department. In addition, because the excise tax would be payable by the Company and not by the redeeming holders, the mechanics of any required payment of the excise tax remains to be determined. Any excise tax payable by us in connection with a Redemption Event may cause a reduction in the cash available to us to complete a Business Combination and could affect our ability to complete a Business Combination.

On February 8, 2023, the Company’s stockholders exercised their right to redeem 1,213,453 shares for a total of $ 12,865,685. The Company evaluated the classification and accounting of the stock redemption under ASC 450, “Contingencies”. ASC 450 states that when a loss contingency exists the likelihood that the future event(s) will confirm the loss or impairment of an asset or the incurrence of a liability can range from probable to remote. A contingent liability must be reviewed at each reporting period to determine appropriate treatment. The Company evaluated the current status and probability of completing a Business Combination as of March 31, 2023, and concluded that it is probable that a contingent liability should be recorded. As of March 31, 2023, the Company recorded $128,657 of excise tax liability calculated as 1% of shares redeemed on February 8, 2023.

NOTE 7. STOCKHOLDERS’ DEFICIT

Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, respectively, there were no shares of preferred stock issued or outstanding.

Common Stock — The Company is authorized to issue 50,000,000 shares of common stock with a par value of $0.0001 per share. At ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021,~~ 2022, there were 3,487,070 shares of common stock issued and outstanding, excluding 43,~~213~~000,~~453~~000 and 124,~~618~~213,~~600~~453 shares of common stock subject to to possible redemption, respectively, which are presented as temporary equity. In connection with the extension on May 12, 2022, stockholders holding 5,586,910 shares of the Company’s redeemable common stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account at a redemption price of approximately $10.30 per share. In connection with the extension on August 17, 2022, stockholders holding 2,818,237 shares of the Company’s redeemable stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account at a redemption price of approximately $10.37 per share. In connection with the extension on February 8, 2023, stockholders holding 1,213,453 shares of the Company’s redeemable stock exercised their right to redeem such shares for a pro rata portion of the funds in the Trust Account at a redemption price of approximately $10.60 per share.

1618

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

NOTE 8. WARRANTS

The Public Warrants will become exercisable on the later of (a) 30 days after the completion of a Business Combination or (b) 12 months from the closing of the Initial Public Offering. No warrants will be exercisable for cash unless the Company has an effective and current registration statement covering the shares of common stock issuable upon exercise of the warrants and a current prospectus relating to such shares of common stock. Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the Public Warrants is not effective within a specified period following the consummation of a Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption provided by Section 3(a)(9) of the Securities Act, provided that such exemption is available. If that exemption, or another exemption, is not available, holders will not be able to exercise their warrants on a cashless basis. The Public Warrants will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation.

The Company may redeem the Public Warrants (excluding the Private Warrants and any warrants underlying units issued upon conversion of the Working Capital Loans):

	●	in whole and not in part;

	●	at a price of $0.01 per warrant;

	●	upon not less than 30 days’ prior written notice of redemption to each warrant holder; and

	●	if, and only if, the last reported sale price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like), for any 20 trading days within a 30 trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders.

If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, except as described below, the warrants will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company be required to net cash settle the warrants. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

In addition, if (x) the Company issues additional common stock or equity-linked securities for capital raising purposes in connection with the closing of a Business Combination at an issue price or effective issue price of less than $9.20 per common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of a Business Combination on the date of the consummation of a Business Combination (net of redemptions), and (z) the volume weighted average trading price of its common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the greater of (i) Market Value or (ii) the price at which the Company issue the additional shares of common stock or equity-linked securities.

The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the shares of common stock issuable upon the exercise of the Private Warrants will not be transferable, assignable or saleable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable for cash or on a cashless basis, at the holder’s option, and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Private Warrants are held by someone other than the initial purchasers or their permitted transferees, the Private Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

1719

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

Representative Shares

On August 5, 2020, the Company issued to EarlyBirdCapital 377,750 shares of common stock (the “Representative Shares”). On November 9, 2020, EarlyBirdCapital returned to the Company for cancellation, at no cost, an aggregate of 75,550 Representative Shares, resulting in an aggregate of 302,200 Representative Shares outstanding and held by EarlyBirdCapital. On November 12, 2020, the Company effected a stock dividend of 0.1 shares for each share of common stock outstanding, resulting in EarlyBirdCapital holding an aggregate of 332,420 Representative Shares. The Company accounted for the Representative Shares as an offering cost of the Initial Public Offering, with a corresponding credit to stockholders’ equity. The Company estimated the fair value of Representative Shares to be $2,666 based upon the price of the Founder Shares issued to the Sponsor. The holders of the Representative Shares have agreed not to transfer, assign or sell any such shares until the completion of a Business Combination. In addition, the holders have agreed (i) to waive their redemption rights with respect to such shares in connection with the completion of a Business Combination and (ii) to waive their rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete a Business Combination within the Combination Period.

Representative Shares

The Representative Shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period of 180 days immediately following the effective date of the registration statement related to the Initial Public Offering pursuant to Rule 5110(g)(1) of FINRA’s NASD Conduct Rules. Pursuant to FINRA Rule 5110(g)(1), these securities will not be sold during the Initial Public Offering, or sold, transferred, assigned, pledged, or hypothecated, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities by any person for a period of 180 days immediately following the effective date of the Initial Public Offering, except to any underwriter and selected dealer participating in the Initial Public Offering and their bona fide officers or partners, provided that all securities so transferred remain subject to the lockup restriction above for the remainder of the time period.

NOTE 9. FAIR VALUE MEASUREMENTS

The Company follows the guidance in ASC 820 for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:

	Level 1:	Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.

	Level 2:	Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.

	Level 3:	Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.

The following table presents information about the Company’s ~~assets~~liabilities that are measured at fair value on a recurring basis at ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022, respectively, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:

Description	Level		~~September, 2022~~	March 31, 2023		~~December 31, 2021~~	December 31, 2022
Assets:
Liabilities:
Marketable securities held in Trust Account	1		$	44,203,481		$	128,790,008
Warrant liabilities – Private Warrants		3		$	581,414		$	528,558
Liabilities:
Convertible promissory note – related party		3		$	914,700		$	901,500
Warrant liabilities – Private Warrants	3		$	422,846		$	2,641,204
Convertible promissory note – related party	3		$	913,900		$	958,400

1820

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

Warrant Liabilities

The Private Warrants were accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the condensed consolidated balance sheets. The warrant liabilities ~~are~~ are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of ~~warrant~~ warrant liabilities in the condensed consolidated statements of operations.

The Private Warrants were valued using a binomial lattice model. The Company allocated the proceeds received from (i) the sale of Units (which is inclusive of one share of common stock and one Public Warrant) and (ii) the sale of Private Warrants, first to the warrants based on their fair values as determined at initial measurement, with the remaining proceeds allocated to common stock subject to possible redemption. The Private Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs.

The following are the inputs used by the Company in establishing the fair value of its Private Warrants at ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~2022.

Input	~~September~~March 3031, ~~2022~~2023			December 31, ~~2021~~2022
Risk-free interest rate		4.0759	%		14.1560	%
Trading days per year		252			252
Expected volatility		54.390	%		95.63	%
Exercise price	$	11.50		$	11.50
Stock Price	$	10.3574		$	10.1745

On December 31, ~~2021~~2022 and ~~September~~March 3031, ~~2022~~2023, the Private Warrants ~~were~~ were determined to be $0.5010 per warrant and $0.0811 per warrant, respectively, for an aggregate value of $20.645 million and $0.46 million, respectively.

The following table presents the changes in the fair value of the warrant liabilities:

	Private Placement
Fair value as of December 31, 2021	$	2,641,204
Fair value as of December 31, 2022	$	528,558
Change in valuation inputs or other assumptions		(152,~~744,591~~856	)
Fair value as of March 31, 2022	$	896,613
Fair value as of March 31, 2023	$	581,414
Change in valuation inputs or other assumptions		(579,785	)
Fair value as of June 30, 2022	$	316,828
Change in valuation inputs or other assumptions		106,018
Fair value as of September 30, 2022	$	422,846

	Private Placement
Fair value as of December 31, 2021	$	2,641,204
Change in valuation inputs or other assumptions		(1,744,591	)
Fair value as of March 31, 2022	$	896,613

BETTER WORLD ACQUISITION CORP.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2022~~2023

(Unaudited)

Convertible Promissory Note – Related Party

The fair value of the option to convert the convertible promissory note into Private Warrants was valued by utilizing a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology.

The estimated fair value of the convertible promissory note was based on the following significant inputs:

	September 30, 2022
	March 31, 2023			December 31, 2022
Risk-free interest rate		04.0059	%		4.60	%
Time to Expiration (in years)		10.381			0.4
Expected volatility		50.30	%		0.0	%
Exercise price	$	11.50		$	11.50
Dividend yield		0.00	%		0.00	%
Stock Price	$	10.3574		$	10.45
Probability of transaction		25.00	%		25.00	%

The following table presents the changes in the fair value of the Level 3 convertible promissory note:

Fair value as of January 1, 2021	$	958,400
Fair value as of January 1, 2023	$	901,500
Proceeds received through Convertible Promissory Note		1,261,860
Change in fair value		13,200
Change in fair value		(337,260	)
Fair value as of March 31, 2023		914,700
Fair value as of March 31, 2022	$	1,883,000
Proceeds received through Convertible Promissory Note		700,000
Change in fair value		(669,000	)
Fair value as of June 30, 2022	$	1,914,000
Conversion of Sponsor advance to Convertible Promissory Note		100,000
Proceeds received through Convertible Promissory Note		360,000
Change in fair value		(1,460,100	)
Fair value as of September 30, 2022		913,900

There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three and nine months ended September 30, 2022 for the convertible promissory note.

Fair value as of January 1, 2022	$	958,400
Proceeds received through Convertible Promissory Note		1,261,860
Change in fair value		(337,260	)
Fair value as of March 31, 2022		1,883,000

There were no transfers in or out of Level 3 from other levels in the fair value hierarchy during the three months ended March 31, 2023 for the convertible promissory note.

NOTE 10. SUBSEQUENT EVENTS

The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as stated below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed consolidated financial statements.

20On April 21, 2023, the Company made a payment to the Trust Account of $120,000 in connection with the extension.

On May 1, 2023, the Company, Heritage, and certain other parties entered into Amendment No. 1 to the Business Combination Agreement (the “Amendment”). The Amendment amends certain provisions of the Business Combination Agreement, dated as of December 9, 2022 (the “Transaction”) to provide for the treatment in the Transaction of the Unsecured Convertible Promissory Notes issued by Heritage between March 8, 2023 and April 1, 2023, in an aggregate amount of $1,830,000 (not including original issue discount and other fees included in the principal amount thereof). Pursuant to the Amendment, the Company and Heritage also agreed that Heritage would be permitted to issue up to an aggregate invested amount of $4,000,000 (not including original issue discount and other fees included in the principal amount thereof) of additional unsecured convertible promissory notes from time to time prior to the Closing, in each case, upon such terms as Heritage and the Company mutually agree prior to any such issuance.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this report (the “Quarterly Report”) to “we,” “us,” “our” or the “Company” refer to Better World Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to BWA Holdings LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations”, the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and ~~similar~~ similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future ~~events~~ events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors ~~could~~ could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 31, ~~2022 and in our Quarterly Reports on Form 10-Q for the period ended March 31, 2022 and June 30, 2022, filed with the SEC on May 13, 2022 and August 3, 2022, respectively~~2023.

Overview

We are a blank check company formed under the laws of the State of Delaware on August 5, 2020 for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (an “initial business combination”). We intend to effectuate our initial business combination using cash from the proceeds of the Initial Public Offering and the sale of the Private Warrants, our capital stock, debt or a combination of cash, stock and debt.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a business combination will be successful.

21Heritage Business Combination

On December 9, 2022, the Company entered into a business combination agreement (the “Business Combination Agreement”) with Heritage Distilling Holding Company, Inc., a Delaware corporation (together with its successors, “Heritage”), Heritage Distilling Group, Inc. (formerly HDH Newco, Inc.), a Delaware corporation and a wholly owned subsidiary of Better World (“Pubco” ), BWA Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Pubco , HD Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Pubco , the Sponsor in the capacity as the representative for the stockholders of the Company and Pubco (other than the former Heritage stockholders), and (vii) Justin Stiefel, in the capacity as the representative for certain security holders of Heritage, for a proposed business combination among the parties .

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities from August 5, 2020 (inception) through ~~September~~March 3031, ~~2022~~2023 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a business combination. We do not expect to generate any operating revenues until after the completion of our business combination. We generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence and transaction expenses.

For the three months ended ~~September~~March 3031, ~~2022~~2023, we had a net ~~income~~loss of $~~844~~607,~~154~~ 372 which consists of ~~the~~change in fair value of warrant liability of $52,856, change in fair value of convertible promissory note – related party of $113,~~113~~200,~~700, interest~~ ~~earned~~a onprovision ~~marketable~~for ~~securities~~income ~~held~~taxes ~~in the Trust Account~~ of $~~254~~54,~~709~~131 and ~~unrealized~~operational ~~gain~~costs ~~on marketable securities held in the Trust Account~~ of $1776,~~078~~732, offset by ~~change~~interest inearned ~~fair~~on ~~value~~marketable ofsecurities held ~~warrant~~in ~~liability~~the ofTrust ~~$106,018,~~Account ~~a provision for income taxes~~ of $23289,~~249 and operational costs of $396,066~~547.

For the ~~nine~~three months ended ~~September~~March 3031, 2022, we we had net income of $31,~~407~~647,~~252~~395 which consists of the change in fair value of warrant liability of $21,~~218~~744,~~358~~591, change in fair value of ~~convertible~~ convertible promissory note – related party of $2337,~~119~~260,~~960,~~ ~~and~~ interest earned on marketable securities held in the Trust Account of $~~423~~52,~~734~~360, ~~offset~~and unrealized bygain ~~provision~~on ~~for~~marketable ~~income~~securities ~~taxes~~held in the Trust Account of $2717,~~528~~283, ~~and~~offset by operational costs of $1504,~~327,272~~099.

For the three months ended September 30, 2021, we had net income of $1,475,730 which consists of the change in fair value of warrant liability of $2,192,941 and interest earned on marketable securities held in the Trust Account of $23,138, and unrealized loss on marketable securities held in the Trust Account of $4,654, offset by formation and operational costs of $735,695.

For the nine months ended September 30, 2021, we had net income of $2,207,258, which consists of the change in fair value of warrant liability of $3,302,913 and interest earned on marketable securities held in the Trust Account of $58,976, and unrealized loss on marketable securities held in the Trust Account of $5,829, offset by formation and operational costs of $1,148,802.

Liquidity and Capital Resources

On November 17, 2020, we consummated the Initial Public Offering of 11,000,000 units, at $10.00 per Unit, generating gross proceeds of $110,000,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of 4,800,000 Private Warrants at a price of $1.00 per Private Warrant in a private placement to our Sponsor and EarlyBirdCapital, Inc. generating gross proceeds of $4,800,000.

On November 19, 2020, in connection with the underwriters’ partial exercise of their over-allotment option, we consummated the sale of an additional 1,618,600 units at a price of $10.00 per unit, generating total gross proceeds of $16,186,000. In addition, we also consummated the sale of an additional 485,580 private placement warrants at $1.00 per private placement warrant, generating total gross proceeds of $485,580.

Following ~~the~~our ~~initial public offering~~IPO, the partial exercise of the ~~over~~ Over-~~allotment~~Allotment ~~option~~Option, and the sale of the private placement warrants, $111,100,000 was placed in the trust account on November 18, 2020 and $16,347,860 was placed in the ~~Trust~~trust ~~Account~~account on November 20, 2020, respectively, for a total of $127,447,860. We incurred $2,880,354 in ~~the initial public offering~~ IPO-related costs, including $2,523,720 of underwriting fees and $356,634 of other costs.

For the ~~nine~~three months ended ~~September~~March 3031, ~~2022~~2023, cash used in operating activities was $~~853~~466,~~148~~727. Net ~~income~~loss of $3607,~~407,252~~372 was affected by the change in fair value of warrant liability of $252,~~218~~856,~~358,~~ change in fair value of convertible promissory note – related party of $213,~~119,960~~200 and interest earned on marketable securities held in the Trust Account of $~~423~~289,~~734~~547. Changes in operating assets and liabilities provided $~~501~~364,~~652~~136 of cash for operating activities.

For the ~~nine~~three months ended ~~September~~March 3031, ~~2021~~2022, ~~cash~~ cash used in operating activities was $~~528~~202,~~273~~335. Net income of $21,~~207~~647,~~258~~395 was affected by the change in fair value of warrant liability of $31,~~302~~744,~~913~~591, change in fair value of convertible promissory note – related party of $337,260, interest earned on marketable securities held in the Trust Account of $5852,~~976~~360, and an unrealized ~~loss~~gain on marketable securities held in ~~our~~the Trust Account of $517,~~829~~283. Changes in operating assets and liabilities provided $~~620~~301,~~529~~764 of cash for operating activities.

As of ~~September~~March 3031, ~~2022~~2023, in the ~~U.S.-based~~ trust account ~~maintained~~had by$32,224,663 (including ~~Continental~~approximately ~~Stock~~$358,699 ~~Transfer~~of &accrued ~~Trust~~interest ~~Company,~~income). ~~acting~~Interest asincome ~~trustee,~~on wethe ~~had~~balance ~~cash~~in ~~held~~the oftrust ~~$947~~account ~~and~~may ~~marketable~~be ~~securities~~used by us to ~~held~~pay intaxes. ~~the~~In ~~Trust~~connection ~~Account~~with ofthe ~~$44,202,534~~extension ~~(including~~on ~~approximately~~May ~~$145~~12,~~311~~ of2022, ~~interest~~stockholders ~~income)~~holding ~~consisting~~5,586,910 shares of ~~securities~~the ~~held~~Company’s inredeemable ~~a money~~common ~~market~~stock ~~fund~~exercised ~~that~~their ~~invests~~right into ~~U.S.~~redeem ~~Treasury~~such ~~securities~~shares ~~with~~for a ~~maturity~~pro ofrata ~~180~~portion ~~days~~of ~~or less. Interest income on~~ the ~~balance~~funds in the trust account ~~may~~at bea ~~used~~redemption byprice usof toapproximately $10.30 ~~pay~~per ~~taxes~~share. In connection with the extension on ~~May~~August 1215, 2022, stockholders holding 52,~~586~~818,~~910~~237 shares of the Company’s redeemable common stock exercised their right to redeem such shares for a pro rata portion of the funds in the ~~Trust Account~~trust account at a redemption price of approximately $10.3037 per share. In connection with the special meeting of stockholders to approve an extension on ~~August~~February 158, ~~2022~~2023, stockholders holding 2 1,~~818~~213,~~237~~453 shares of the Company’s redeemable common stock exercised their right to redeem such shares for a pro rata portion of the funds onin the ~~Trust~~trust ~~Account~~account at a redemption price of approximately $10.3760 per share. Through ~~September~~March 3031, ~~2022~~2023, we have withdrawn $~~358~~614,~~711~~534 of interest earned on the trust account to pay our taxes and $99,639,095 from trust account in connection with the redemptions.

2224

We intend to use substantially all of the funds held in the trust account, to acquire a target business and to pay our expenses relating thereto upon consummation of our initial business combination ~~for assisting us in connection with our initial business combination~~. To the extent that our capital stock is used in whole or in part as consideration to effect an initial business combination, the remaining funds held in the trust account will be used as working capital to finance the operations of the target business. Such working capital funds could be used in a variety of ways, including continuing or expanding the target business’ operations, for strategic acquisitions and for marketing, research and development of existing or new products. Such funds could also be used to repay any operating expenses or finders’ fees ~~which~~that we had incurred prior to the completion of our initial business combination if the funds available to us outside of the trust account were insufficient to cover such expenses.

As of ~~September~~March 3031, ~~2022~~2023, we had cash of $83141,~~760~~465 held outside the trust account. We intend to use the funds held outside the trust account for closing the Heritage Business Combination, identifying and evaluating prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices, plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target businesses, selecting the target business to acquire and structuring, negotiating and consummating the initial business combination.

In order to fund working capital deficiencies or finance transaction costs in connection with an initial business combination, ~~the~~our ~~insiders,~~sponsor or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete our initial business combination, we would repay such loaned amounts. In the event that our initial business combination does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.00 per warrant, at the option of the lender. ~~The~~Such ~~units~~warrants would be identical to the private placement warrants. On November 9, 2021, we issued athe ~~promissory~~Sponsor ~~note~~Note in the principal amount of $1,261,860 to ~~the~~our ~~Sponsor~~sponsor in connection with an extension of the ~~Extension~~date ~~(“Convertible~~by ~~Promissory~~which ~~Note”)~~we ~~(as~~have ~~defined~~to ~~below)~~consummate an initial business combination. On February 17, 2022, ~~April~~ 14May 17, 2022, ~~May~~August 1817, 2022, and ~~August~~December 1731, 2022, we amended and restated the ~~Convertible~~Sponsor ~~Promissory~~ Note to increase the principal ~~amount~~ amount thereunder from $1,261,860 to $34,~~683~~323,720. The Sponsor Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which ~~the~~we ~~Company’s~~consummate ~~Business~~our ~~Combination~~initial isbusiness ~~consummated~~combination and (ii) the liquidation of the Company on or before ~~February~~August 17, 2023 or such later liquidation date as may be approved by the Company’s stockholders. At the election of ~~the~~our ~~Sponsor~~sponsor, up to $1,500,000 of the unpaid principal amount of the ~~Convertible~~Sponsor ~~Promissory~~ Note may be converted into warrants of the Company, each warrant exercisable for one share of common stock ~~of the Company~~ upon the consummation of ~~its~~our ~~Business~~initial ~~Combination~~business combination, equal to: (x) the portion of the principal amount of the ~~Note~~Sponsor Note being converted, divided by (y) $1.00, rounded up to the nearest whole number of warrants.

On January 31, 2023, February 28, 2023, March 29, 2023, and March 31, 2023, the Sponsor advanced to us an aggregate amount of $710,000.

We expect that we will need to raise additional capital through loans or additional investments from our sponsor, stockholders, officers, directors, or third parties. Our officers, directors and sponsor may, but are not obligated to, loan us funds, from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet our working capital needs. Accordingly, we may not be able to obtain additional financing. If we are unable to raise additional capital, we may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. We cannot provide any assurance that new financing will be available to us on commercially acceptable terms, if at all.

In connection with ~~the~~our ~~Company’s~~ assessment of going concern considerations in accordance with ~~Financial Accounting Standard Board~~FASB’s ~~Accounting Standards Update (“~~ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” ~~the~~we ~~Company~~have ~~has~~ until ~~February~~ August 17, 2023 to consummate aan ~~Business~~initial ~~Combination~~business combination. It is uncertain that ~~the~~we ~~Company~~ will be able to consummate a ~~Business~~business ~~Combination~~ combination by this time. If a ~~Business~~business ~~Combination~~combination is not consummated by this date and an extension has not been requested by ~~the~~our ~~Sponsor~~sponsor and approved by ~~the~~our ~~Company’s~~ stockholders, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and the mandatory liquidation and potential subsequent dissolution raises substantial doubt about ~~the~~ ~~Company’s~~our ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should ~~the~~we ~~Company~~ be required to liquidate after ~~February~~August 17, 2023. ~~The~~We ~~Company~~intend ~~intends~~ to ~~continue to search for and seek to~~ complete a ~~Business~~business ~~Combination~~combination before the mandatory liquidation date. ~~The Company is within 12 months of its mandatory liquidation date as of the time of filing of this Quarterly Report on Form 10-Q.~~

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of ~~September~~March 3031, ~~2022~~2023. We do not participate in transactions that create ~~relationships~~ relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

2325

Contractual Obligations

We have agreed, commencing on November 12, 2020 through the earlier of our consummation of an initial business combination and our liquidation, to pay an affiliate of our management a total of $10,000 per month for office space, utilities and secretarial support. For the three ~~and nine~~ months ended ~~September~~March 3031, ~~2022~~2023, the Company incurred ~~and accrued~~ $30,000 ~~and $90~~,~~000~~ in fees for these services, ~~respectively,~~of ~~and~~which ~~those~~such ~~fees~~amounts are included in ~~accounts payable and~~ accrued expenses in the accompanying condensed consolidated balance sheets. For the three ~~and nine~~ months ended ~~September~~March 3031, ~~2021~~2022, the Company incurred and paid $30,000 ~~and $90~~,~~000~~ in fees for these services, of which such amounts are included in accrued expenses in the accompanying condensed consolidated balance sheets.

We granted the underwriters a 45-day option from the date of the initial public offering to purchase up to 1,650,000 additional units to cover over-allotments, if any, at the initial public offering price less the underwriting discounts and commissions. On November 19, 2020, the underwriters partially exercised their over-allotment option to purchase an additional 1,618,600 units at $10.00 per unit and forfeited the remaining over-allotment option.

We have engaged EarlyBirdCapital as an advisor in connection with an initial business combination to assist us in holding meetings with its stockholders to discuss the potential initial business combination and the target business’ attributes, introduce us to potential investors that are interested in purchasing our securities in connection with an initial business combination, assist us in obtaining stockholder approval for the initial business combination and assist us with our press releases and public filings in connection with the initial business combination. We will pay EarlyBirdCapital a cash fee for such services upon the consummation of an initial business combination in an amount equal to 3.5% of the gross proceeds of the initial public offering, or $4,416,510 (exclusive of any applicable finders’ fees which might become payable); provided that up to 30% of the fee may be allocated at our sole discretion to other FINRA members that assist us in identifying and consummating an initial business combination.

Additionally, we will pay EarlyBirdCapital a cash fee equal to 1.0% of the total consideration payable in an initial business combination if EarlyBirdCapital introduces us to the target business with which we complete an initial business combination.

We have engaged various law firms to provide legal due diligence services and business combination services related to potential target companies. All fees and expenses related to the various engagements will be deferred and are to be paid fully upon the closing of any business combination. The law firms will not be entitled to any contingent fees or expense reimbursement if we do not consummate an initial business combination within our deadline. Deferred fees of $1,~~371~~821,~~549~~ 825 and $1,~~009~~654,~~868~~062 related to these legal services have been accrued as of ~~September~~March 3031, ~~2022~~2023 and December 31, ~~2021~~ 2022, respectively.

Critical Accounting Policies

The preparation of condensed ~~financial~~consolidated ~~statements~~financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“GAAP”), which requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:

Warrant Liability

The Company accounts for the Private Warrants in accordance with the guidance contained in ASC 815-40-15-7D and 7F under which the Private Warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the Private Warrants as liabilities at their fair value and adjusts the Private Warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in our statements of operations. The Private Warrants for periods where no observable traded price was available are valued using a binomial lattice simulation model.

2426

~~Convertible~~Sponsor ~~Promissory~~ Note

We account for ~~our~~the ~~convertible~~Sponsor ~~promissory~~Note ~~note~~ under ASC 815, Derivatives and Hedging (“ASC 815”). Under 815-15-25, the election can be at the inception of a financial instrument to account for the instrument under the fair value option under ASC 825. We have made such election for ~~our~~the ~~convertible~~Sponsor ~~promissory note~~Note. Using the fair value option, the ~~convertible~~Sponsor ~~promissory~~Note ~~note~~ is required to be recorded at its initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the note are recognized as non-cash change in the fair value of the ~~convertible~~Sponsor ~~promissory~~Note ~~note~~ in the statements of operations. The fair value of the option to convert the ~~convertible~~Sponsor ~~promissory note~~Note into private placement warrants was valued by utilizing a binomial lattice model incorporating the Cox-Ross-Rubenstein methodology.

Common Stock Subject to Possible Redemption

We account for our common stock subject to possible conversion in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and measured at fair value. ~~Conditionally~~ Conditionally redeemable common stock (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. Our common stock features certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of our condensed consolidated balance sheets.

Net (Loss) Income per Common Share

Net (loss) income per common share is computed by dividing net (loss) income by the weighted average number of common shares outstanding for the period. Accretion associated with the redeemable shares of common stock is excluded from net (loss) income per common share as the redemption value approximates fair value.

Recent Accounting Standards

In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity” (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, and it also simplifies the diluted earnings per share calculation in certain areas. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company assessed the potential impact of ASU 2020-06 and determined that it would not have a material impact on the condensed consolidated financial statements as presented.

Management does not believe that any other recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed consolidated financial statements.

Factors That May Adversely Affect Our Results of Operations

Our results of operation and our ability to complete an initial business combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond our control. Our business could be impacted by, among other things, volatility in the financial markets or economic conditions, increase of oil price and interest rate, inflation, supply chain disruption, decline in consumer confidence and spending, the on-going effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in Ukraine. We cannot at this time fully predict one or more of the above events, their duration or magnitude of, or the extent to, which they may negatively impact our business and our ability to complete an initial business combination.

2527

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Not required for smaller reporting companies.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls and procedures are also designed with the objective of ensuring that such information is accumulated and communicated to our management, including the chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

As required by Rule 13a-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of our disclosure controls and procedures as of ~~September~~March 3031, ~~2022~~2023. Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded ~~that~~ that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) were not effective, due solely to the material weakness in our internal control over financial reporting related to our accounting for complex financial instruments. As a result, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with GAAP. Accordingly, management believes that the financial statements included in this Report present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

Management has identified a material weakness in our internal controls related to the accounting for complex financial instruments. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to continue to enhance our system of evaluating and implementing the accounting standards that apply to our financial statements, including through enhanced analyses by our personnel and third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the intended effects.

Management has implemented remediation steps to improve our internal control over financial reporting. Specifically, we expanded and improved our review process for complex securities and related accounting standards. We plan to further improve this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

2628

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

To the knowledge of our management team, there is no litigation currently pending or contemplated against us, any of our officers or directors in their capacity as such or against any of our property.

Item 1A. Risk Factors

As of the date of this Quarterly Report on Form 10-Q, except as disclosed below, there have been no material changes to the risk factors previously disclosed in our final prospectus filed with the SEC on November 17, 2020 , in our Annual Report on Form 10-K for the year ended December 31, ~~2021~~2022 filed with the SEC on ~~March~~ ~~31, 2022 and in our Quarterly Reports on Form 10-Q for the period ended~~ March 31, ~~2022 and June 30, 2022, filed with the SEC on May 13, 2022 and August 3, 2022, respectively~~2023. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. We may disclose changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

AMarket ~~new~~conditions, 1%economic ~~U.S.~~uncertainty ~~federal excise~~or ~~tax~~ downturns could beadversely ~~imposed~~affect ~~on us in connection with redemptions of~~ our ~~shares in connection with a~~ business, ~~combination~~financial orcondition, ~~other stockholder~~operating ~~vote~~results ~~pursuant~~and toour ~~which~~ability ~~stockholders would have a right~~ to ~~submit~~consummate ~~their shares for redemption (~~a ~~“Redemption~~Business ~~Event”)~~Combination.

OnIn ~~August~~recent 16years, ~~2022,~~ the ~~Inflation~~United States ~~Reduction~~and ~~Act~~other ofmarkets ~~2022~~have ~~(the~~experienced ~~“IR~~cyclical ~~Act”)~~or ~~was~~episodic ~~signed~~downturns, ~~into~~and ~~federal~~worldwide ~~law.~~economic ~~The~~conditions IRremain ~~Act provides for~~uncertain, ~~among~~including ~~other~~as ~~things,~~ a ~~new U.S.~~ ~~federal~~result ~~1% excise tax on certain repurchases (including redemptions)~~ of ~~stock by publicly traded domestic corporations and certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on~~ the ~~repurchasing~~COVID-19 ~~corporation itself~~pandemic, ~~not~~supply ~~its~~chain ~~stockholders from~~disruptions, ~~whom shares are repurchased. The amount of~~ the ~~excise~~Ukraine-Russia ~~tax~~conflict, isinstability ~~generally~~in ~~1% of~~ the ~~fair~~U.S. ~~market~~and ~~value~~global ofbanking ~~the shares repurchased at~~systems, ~~the~~rising ~~time~~fuel ~~of the repurchase. However~~prices, ~~for~~increasing ~~purposes~~interest ofrates ~~calculating~~or ~~the~~foreign ~~excise~~exchange ~~tax,~~rates ~~repurchasing~~and ~~corporations~~high ~~are~~inflation ~~permitted~~and ~~to net~~ the ~~fair market~~possibility ~~value~~ of ~~certain~~a ~~new stock issuances against the fair market value of stock repurchases during the same taxable year~~recession. InA ~~addition,~~significant ~~certain~~downturn ~~exceptions~~in ~~apply~~economic toconditions ~~the~~may ~~excise~~make ~~tax.~~it ~~The~~more ~~U.S.~~difficult ~~Department~~for ofus ~~the Treasury has been given authority~~ to ~~provide~~consummate ~~regulations~~a ~~and~~Business ~~other guidance to carry out and prevent the abuse or avoidance of the excise tax~~Combination. ~~The IR Act applies only to repurchases that occur after December 31, 2022.~~

~~Any~~We cannot ~~redemption~~predict the timing, strength, or ~~other~~duration ~~repurchase~~of ~~that~~any ~~occurs~~future ~~after~~economic ~~December~~slowdown ~~31,~~or ~~2022~~any subsequent recovery generally, or in ~~connection~~any ~~with~~industry. If athe ~~Redemption~~conditions ~~Event~~in ~~may~~the begeneral ~~subject~~economy toand the ~~excise~~markets ~~tax.~~in ~~Whether~~which we operate worsen from present levels, our business, financial condition, operating results and our ability to ~~what~~consummate ~~extent~~a weBusiness ~~would~~Combination could be ~~subject~~adversely toaffected. ~~the~~For ~~excise~~example, ~~tax~~ in ~~connection~~January ~~with~~2023, athe outstanding ~~Redemption~~national ~~Event~~debt ~~would~~of ~~depend~~the onU.S. agovernment ~~number~~reached its statutory limit. The U.S. Department of ~~factors,~~the ~~including~~Treasury (ithe “Treasury Department”) ~~the~~has ~~fair~~announced ~~market~~that, ~~value~~since ofthen, ~~the~~it ~~redemptions~~has ~~and repurchases~~been inusing ~~connection~~extraordinary ~~with~~measures to prevent the ~~Redemption~~U.S. ~~Event~~government’s default on its payment obligations, ~~(ii)~~and to extend the ~~structure~~time ofthat the ~~business~~U.S. ~~combination,~~government ~~(iii)~~has ~~the~~to ~~nature~~raise ~~and~~its ~~amount~~statutory ofdebt ~~any “PIPE”~~limit or ~~other~~otherwise ~~equity~~resolve its ~~issuances~~funding insituation. ~~connection~~The ~~with~~failure ~~the~~by ~~business~~Congress ~~combination~~to ~~(or~~raise ~~otherwise~~the ~~issued~~federal ~~not~~debt inceiling ~~connection~~could ~~with~~have severe repercussions within the U.S. and to ~~Redemption~~global ~~Event~~credit ~~but~~and ~~issued~~financial ~~within~~markets. ~~the~~If ~~same~~Congress ~~taxable~~does ~~year~~not ofraise the ~~business~~debt ~~combination)~~ceiling, ~~and~~the ~~(iv)~~U.S. ~~the~~government ~~content~~could ofdefault ~~regulations~~on ~~and~~its ~~other~~payment ~~guidance~~obligations, ~~from~~or experience delays in making payments when due. A payment default or delay by the U.S. ~~Department~~government, ofor continued uncertainty surrounding the ~~Treasury~~U.S. Indebt ~~addition~~ceiling, ~~because~~could ~~the~~result ~~excise~~in ~~tax~~a ~~would~~variety beof ~~payable~~adverse byeffects usfor financial markets, market participants and ~~not~~U.S. byand ~~the~~global ~~redeeming~~economic conditions. In ~~holder~~addition, U.S. debt ceiling and budget deficit concerns have increased the ~~mechanics~~possibility ofa ~~any~~downgrade ~~required~~in ~~payment~~the credit rating of the ~~excise~~U.S. ~~tax~~government ~~have~~and ~~not~~could ~~been~~result ~~determined~~in economic slowdowns or a recession in the U.S. ~~The~~Although ~~foregoing~~U.S. ~~could~~lawmakers ~~cause~~have apassed ~~reduction~~legislation into raise the ~~cash~~federal debt ~~available~~ ceiling on multiple ~~hand~~occasions, ratings agencies have lowered or threatened to ~~complete~~lower the long-term sovereign credit rating on the United States as a result of disputes over the debt ceiling. The impact of a potential downgrade to the U.S. government’s sovereign credit rating or its perceived creditworthiness could adversely affect economic conditions, as well as our business, ~~combination~~financial ~~and~~condition, inoperating results and our ability to ~~complete~~consummate a ~~business~~Business ~~combination~~Combination.

To mitigate the risk that we might be deemed to be an investment company for purposes of the Investment Company Act, we expect to instruct the trustee to liquidate the securities held in our trust account and instead to hold the funds in our trust account in cash items until the earlier of the consummation of our initial business combination or our liquidation. As a result, we will likely receive minimal interest, if any, on the funds held in the trust account, which will likely reduce the dollar amount our public stockholders would receive upon any redemption or liquidation of the Company.

The funds in our trust account have, since our initial public offering, been held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment Company Act. However, to mitigate the risk of us being deemed to be an unregistered investment company (including under the subjective test of Section 3(a)(1)(A) of the Investment Company Act) and thus subject to regulation under the Investment Company Act, we expect to instruct Continental Stock Transfer & Trust Company, the trustee with respect to our trust account, to liquidate the U.S. government treasury obligations and money market funds held in the trust account and to hold all funds in the trust account as cash items until the earlier of the consummation of our initial business combination or the liquidation of the Company. Following such liquidation, we will likely receive minimal interest, if any, on the funds held in the trust account. However, interest previously earned on the funds held in the trust account still may be released to us to pay our taxes, if any. This will likely reduce the dollar amount our public stockholders would receive upon any redemption or liquidation of the Company. In the event that we may be deemed to be an investment company, we may be required to liquidate the Company.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

None.

Item 5. Other Information

None.

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.		Description of Exhibit
3.1		~~Second~~Third Amendment to the Amended and Restated Certificate of Incorporation, as amended (Incorporated by reference to the Company’s Form 8-K filed on ~~August~~February 1713, ~~2022~~2023)
10.1		Third Amended and Restated Promissory Note, dated August 17, 2022 (Incorporated by reference to the Company’s Form 8-K filed on August 17, 2022)
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*		Inline XBRL Instance Document
101.SCH*		Inline XBRL Taxonomy Extension Schema Document
101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*		Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*		Cover Page Interactive Data File

*	Filed herewith.
**	Furnished herewith.

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BETTER WORLD ACQUISITION CORP.
Date: November 14, 2022	By:	/s/ Rosemary L. Ripley
Date: May 19, 2023	By:	/s/ Rosemary L. Ripley
	Name:	Rosemary L. Ripley
	Title:	Chief Executive Officer
		(Principal Executive Officer)
Date: November 14, 2022	By:	/s/ Peter S.H. Grubstein
Date: May 19, 2023	By:	/s/ Peter S.H. Grubstein
	Name:	Peter S.H. Grubstein
	Title:	Chief Financial Officer
		(Principal Financial Officer)

Filing Compare · Better World Acquisition Corp.